throbber
C<531'i‘¥i§E«AiWG Eb3:§:ifi§N
`
`BIOPHARMACEUTICAL ASPECTS
`OF ENTESTSNAL DRUG
`ABSORPTIQN
`Prof Freza Fassihi
`
`iary bimad-cf the i'T&ESBi‘fiBTiC circuiaiian and ncfi ‘go include the
`appearance of medrug in zhe 33:5-terni: cireuiation. This‘ dis-
`tinciisn is made because between the gm and the: systemic
`circulaiien. has-the War, the great "iJD‘!sonv trap”.. profecfmg We
`$1.-'s!e'm§c circulation from numerous potential toxins which
`ante? the gastrointesnnal tract‘ Evoiuiianarg experience cf
`environ memai Toxins have pmvided the Iiver sézirh an eyaraz;-r«
`€L33i"rfil‘_‘_,! range of detinxicating mechanisms for namrai toxinfi
`which are active in detoxicating minidrugs. The verypres—
`arms of thee. irap, means that for many drugs. aii ‘mat is ab-
`sxsmed {Seas nut enter the $;*,r$l'erni<: circuiatiun intact. This is
`known as me “firs! pass em-’:;i”. Drugs that shew a substan-
`tiai -first pass effeci ‘n man due to hegzatiii elimination are
`iisiedin "F-abie 1 .
`
`“fable 1 : Drugs ‘showing tear; orai béioavaisaizziiity due in exten-
`sive. firm—pass hepatic slim-inaticm
`Mérca_ptep”urine
`Acetylaaiicyiia acid
`Meihyibheriidate
`Aiprennidl
`Matepmioi
`Amitriptyiine
`Ghécrmethiozele
`Morphifie
`Cs:-umarin
`Naaostigmine
`Nate-cxipine
`Des'ipram.ine
`Nariryptyiine
`Dextr‘q:.>rc:s>axyphena
`Oxyphenbutazone
`Diiéydroergeiamine
`Diitiazem
`Papawfine
`Dopamine
`Pentazccine
`Piéentacelin
`5:F!uorouracia
`Praprancm:
`Giizsceryiirinitrate
`Reserpine
`Hydraiazme
`S9.-ncyiamide
`imipramine
`Serdtxtmin
`isaproterenm
`Testostercme
`Labeioioi
`Trypiephan
`Lignccaine
`Verapamiti
`
`The motility at the smaii intestine tends ‘to optimise cliges--
`técm and absorption. There are primaciiy two iypes ofiniesfinai
`msvement: peristalsis and mixing. Petistaisis determines im
`testing} transit, raie anti theréfare the residence ‘time Ufa drug
`in ihe intesfine. This wiii be most impartant for cczhtrniied #9»
`%éase dosage. forms, enteric casted products as wail as tmse
`drugs which disso.1ve'sI¢_w1y or where afisorpfion is maximal
`aniy in certain ragions of the intestine,» Mixing air ‘segmeniai
`
`253
`
`E N DO_O P_1348761
`
`FACTORS AFFECTING GASTRDENTESTENAL
`ABSDRFTEON
`
`As 3 r'u'ié-, about ?S% of the drag given cgraiigiwili be absorbed
`in cine to three hams. but numerous factcirs can after ‘this,
`some physizfiogical and same to on wiih Iheftsrmulation oi the
`drug. The main factors are:
`1.
`gasirointestinaj motiiiiy
`spianohnic biaud flow
`particie size and drug-dei§va:y‘sy%stem
`
`2 3
`
`.
`
`chemicai factors and drug interacticnsi
`pathaphysiuisgic cuzxdiiimxs.
`
`4 5
`
`After passing th :1:-ugh the pyiaric spitinc1er,'-firug reaches. in
`sequence, -the duadenum. jeiunum and ileum. Thase regians
`have different pH, -digasxive s3nzyme.s"and abscrptive capapi-
`ties. The gelease of food into the cucgdebum causes the
`release of éhniecystokininmancreéiymin and secreiin by
`ztuodenai muccsa, which cause‘: emptying of the gaiitaiadcier,
`secreténn of pancreatic enzymes, and flow (of pancreatic and
`biliary fluid, Bike, which has a {JH of 7,B—8.,8, raisas the pH of
`the dmdenai anti p:3st—duoder:a! intasxina! cements to ap-
`praxknataiy 5-?. Bile saits; w~hi€;—§’3 are surfacaactéve, can pro-
`mate dissoiufion of iipqphiiic drugs and__m.ay aiso increase
`membrane pemieabiiiiy of hydméhabic drug moiecuies
`tbro‘u‘gh_mi<:e!ie forrnafion and sslabéiizaticii.
`it has been
`reamed Ehat bile
`saits
`farm ihscziutvie nonabsorbabie
`compiexes wiih drugs such a neomycin. kanatrrycin and van-
`comycism. Poiyytxeptides such as corticotropin. vasoprassin
`and irxsillin at-3 fiiso rapidtgr degraded by the iritasiinaj en-
`zymes and pirogestercme, testesterdhe =afid aidosteronew are
`simiifiriy unstabie in the intestine Malling, 1980; Meiahder.
`‘:9?& .
`The process of drug abscrpfior: fmm oral formuiations
`irwafsres passage of the drug acmss the gastrsintesiinai
`rtustifisa,
`intm the mesenteric vcircuiaiion
`in the present
`siisxcussiorn, absarption wiii be taken is mean txniy the gmeess
`of passage acress the gastrdintesiinal muccesa info the capit-
`
`P;“bfAFt Fa:-;si‘hz_', D.ep1‘..m' Pharmacy, Iiiemcas Schaol, unziver.
`srrysftne mtwafersranct York Road, Parkfown.
`
`SA Phafifiaceuficai Journat-—Juiy 1 990
`
`Lupin Exh. 1028
`
`

`
`(:é::1“EITi’£_?IN£} E,DUC{g1g>N
`
`Saiufienfi Peilets <2 2 mm iwgrggggigggggina
`L8
`HB
`F
`1.8
`‘fie
`
`%
`
`11
`
`.
`
`*"an g.
`
`P.onao:-aQ
`
`:o
`n
`
`4-.
`
`ouan4-a
`o.
`v.
`ov.
`v
`u«up.anu
`
`
`o.u.uv
`
`I9
`4.
`an..u.
`
`«-
`
`
`
`
`
`Smalli.ntes.t‘metransitt:ime(h3
`
`
`
`
`
`contractions serve ‘to mix and squeeze the faofi 10 prrsmeia
`sp:'_ead_in§; and c:1niaetwith.:he intestvinai vmi. in adadiiiora, the
`musquiaris mucosa produces {aids in the surface epithetium
`resufiing in an increased surface area and rate of absorption,
`The villi-centraci during this process and resuit in a “mi%king"
`actéen so that lymph fiows from the central Iacieal into the
`{ymphaiic sysiem.
`In maiabsorption states, or in .pa‘t‘zent's wfm imestinai resec-
`ficans absorption 0% some drugs may be impaired fag, digexin,
`thymxine). in patients with gafirointestinai hurry the aizsarzy
`'£i0f‘£ of drugs from stew refease preparaties:-ns may be im—
`paired. in sutjh. cases an akiernafive (eg. effervegcent potas-
`sium salts rather -than a slow reseaz-as preparatéan) should be
`used. Gastro%rr($es!i»nai ioxicity ofdrugs czanbe d%videdinh:> two
`grcups, awarding to severity. The first inciudes {ass serious
`effects such as nausea, vomiting and diarrheea anti second.
`seriauvs afiects such .as,,gastroimestinat erosfitsn, 1;-Seeding and
`uiceraiion Nausea and ‘vomiting are commciniy aaseciated
`with drugs such as pataséium tit:§:3ri<3e_.
`'ami‘n£3;§hyl|ine and
`ferrous sjuiphate. Petasssium chlaride arse causes the more
`$2-rious affects of eroséon and utcaramn, as was aspirin.
`Same. malty administerad drug-s aremore extensixteiy -meiafim
`czfised. in the intestine than in the lisiar. Thus, 'intestEna} .metab-
`ofism may crsnifibute in the uverafl first pass effect. First pass
`effect may so greatly iimit. the bfioabaiiabiifity af e;ra1!y‘a::Iminis—
`fared drugs thai a{temat§ve rs-ate-3 of administration must be
`employed is achieve iherapeuficaiiy ef§.emive biead Eeveis.
`Examples of mucc:3'aE'metab1:sfEsm of some drugs. are Shawn
`in Tab§e'2 (Ritschel 198.6).
`
`‘E“ab'2a‘2: Examgxes cf 8-come drugs for which gastroiniteatiraai
`metaboiism apply
`
`Acsaiwsaiicyiic acid
`Aidesie rune
`P-AmԤ.mt:anzoic: acid
`P~Amir:c:h'i;3puric acid
`Chlorprmnazine
`Cbnazepam
`Corfisone
`Hydrowfiisane
`Meperidine
`
`Methadcxne
`an-Methyédapa
`Peniaztaairée
`Progesierone
`Stiihestrol
`SnEonamides
`Terbutaline
`
`Natev: The drug meiaboiisiag enzymes normaiiy assaciateé
`with hapatic tissue have an been iaund if: tha iniestinai
`mucosa sf ammais and -man iflatftiaia, 1973;‘ Thus the syn»
`thatic reactions (oxidation, reductions and hydrolysis) as wen
`as the conjugation reactions rrormaliyv associated with deh:)x§~
`catian are as’ catalysed» by gm enzymes fieg, Gym-chrame
`P-450, aioohot ciehycétogenase, MAO} {Inga ciecarkmxyiase.
`reductases. esterasas, arnidases, acetyiase. sulphokinases,
`glucuronyi transferases and amino acid conjugates»). The
`lower gut also hafbaurs intesiinai microofganisms éhat are
`Capable ofmanax bintransfcsrrnafiori reactions.
`The mean transit time 13:’ unabsorbed fond resa'dues or in«
`soluble. grannies, paeéiets, Earge unirdosage fmms and 50%-
`utions through the human smafl intestine is remarkabiy con-
`.sfe'm’c and "is estimated-tarbe about 4 hr, Figure 1 {Davis e? as;
`19.8%}. ‘fhe resufts eif’ severe} investigations hava revealed
`>2?‘-fiat this ifitasiinak traifrsii time in 'h’ea.£$h}:. subjects is not in
`ffuencad by the presence raf faod. «exercise and densiiy of the;
`mzateriais. it appears mat physioiagicat discrimmaiizm sf meat:
`semis and liquids takes. mace infihe stcmach ratherihan the
`smafl be:-we!. However,
`intestin‘a¥' transit rate is decreased
`where there is a Teduciiart in digestive iuice secrefian and ’(h:.*«
`refine secretion, and is increased with diajrmneai cenditmns
`and during énsufin hyipogtycaemia. Drugs whose abscnrptian
`can be delayed, decreased er enhanced why‘: taken with
`P118815 are Eisted in Tame 33 and 4, respectively.
`
`260
`
`"'~nrv‘:~:--'n..auIz*-1r‘r2
`
`'5
`
`4
`
`6
`
`6
`
`3
`
`-..
`
`Number of subjects
`
`Figure 1: Range cf individuai data. points etxsamed in
`subjecis studied "far intestinanransit time cf pharmaceuiical
`damage forms according to feeding condiflans using gamma
`scintégraphy
`Kasai: F -— fasted; LB ~» fight brea!-zfasé (1 500 ml} ; -HB—— ‘heavy
`bzeakfast gage 3-:3
`A
`(F3543 mwdi ' dfram aws errai, mash}.
`
`Tabse 3.: Drugs whnse. absorption can be deiayad {Group I} 4::
`decreased ‘(Grants 11} by feed sr nutrients
`
`
`
` Group 1* Group II*
`
`Amépicimn
`Penicikiinsfe. VH3
`Tetracycfines
`Antipyrifiev
`iseniazid
`Chiarpromazide
`Capmprif
`Levociiapa
`.Fiifampic:ir:
`Lincsmycin
`Proguantheiine
`
`Acetaminophen
`Ampiciilm
`Amoxicifiin
`Aspirin
`Aiciuéenac
`Cepfiaiaspsfins
`Gimeticiine
`Digoxin
`F’urose_mide
`lndo;1'ro'fen
`Potassium
`Metrcmidazofe
`Pirexicam
`Sifitenamides
`Valproic acid
`Quinidine
`
`*T?:e eifecfs ofrhese drugs ml? bra enhancer! when taken on an empty
`stcrnach
`
`Note: There -are.c»:mfi‘sc’:inQ reports concerning .abso:'ption gf
`drugs in the presermaiand absance :23‘ food and it is {iiiffi-?;uIt“xrD
`generazize, from the infzzrmation given abmra. Hswevec,
`detayed absorption in this coniexi means amt drug ::i'oax:a?%-
`abifity is net affected but me onset sf action is deéayed. Ge-
`craased absorptian means» ihat drug h't0auaf'abi}ity- is af-
`faded.
`
`Tabie 4: Urugsztcz be taken with-meats
`Acatyl-leucine
`Metfarmin
`Aseiylsalicylic acid:
`Methysergidaé
`Aiciofenac
`Metiazi niic acid
`Aiiopurinof
`Matoprzfloi
`Amicsdarone
`Mexranidazale
`
`SA Tydsmt *.x§rApteeb:wese--—dulée 199:3
`
`
`
`ENDO_OP__1348762
`
`

`
`
`
`CCiNTINl}1l$:G.EI)UcATI(JN
`
`ii?‘
`Haciruia 5~.:miuosalicy;:lic acid
`
`COG“
`
`9.:-:\dl$3i
`
`_
`
`i CmcinicM...
`I-xnawro bic
`
`A231:-mpazene
`Baciofen
`Berixbrcamsrnne
`Benziodamne
`Bmmocri piine
`-Qariiamazepine
`Ghlofai hydrate
`Cinnarizine
`Co—trimo>:azoie
`Ciiazgpam
`Diclofenac sodium
`Dicoumaml
`Diitalene
`Discipyramide
`Eihambulol
`Flavaxaie
`Giibencamide
`Glibarrruride
`Glicazicle
`Giipizlde
`Griseoiulvin
`Hydzralazine
`i-iydrcschiorethiaziije
`lbu prolen
`indemelhacin
`Eran salts
`lsexsurpine
`Label»:-lol
`Lavodopa
`Licleflazine
`Lithium clfrate
`
`Minocyiclitte
`Nalidixic acid
`Naproxen
`Nlcoiihiii acid -l- defivatives
`i.\';’ifii;i rink: acid
`iiiiiu r:9i'néai
`l\3ltroillréaii’icin
`Oxyphénbulazbné
`Panéréalin
`Pheynlbulaztrne
`Phenytoin
`Pivaiiépirsillln
`Potassium salis
`Pmp»ra'n0|ol
`Reserpine
`Flltaailavine
`Spiionslactone
`Suiindaz:
`Su'lpihlrl_pyrazi3ne
`Theophyliine :4 derivatives
`Tinidazole
`Tclazamide
`Toibutamide
`Tdlmeiin sadium
`Triamterene
`Vaiprfiaié stadium
`8~ Meihoxsalen
`5~FiLlrc>ura'c'il
`
`Nata: ihe effects ai these drugs will be enhanceii when taken
`with meals.
`
`TF\‘13iNSiT KND DR UG ABSOFE F‘Ti0N ill! THE COLOR
`
`The distal portion of the gastrointestinal tracl, the colon, has
`as its primary iunciion wallet and electrolyte absorptican (prox-
`ima hall} and the storage cf faeczal matter print in its being
`exiiselled {dlslal half). Qrug .abs»::r;3ti{5n from lime colon is likely
`in be quite slow in comparlsan with iiie small Ernestine tile’-
`cabse of the small surface area available for absorptien.
`Patients who take nc-n'—steroidaii
`.anii~inflammatory drugs
`have an increased incidence of gasiric biaeding and peptic
`ulceration. Thus cases have been reported in which incleme-
`ihagin delivered in an osmotic pump was associated with in-
`teatinai perforation. Single unit dosage forms can be hréid for
`long periods {442 h) at the iiencaecal ‘salve before moving
`inta the cQlcm..»Coi<::n ccvritents are nriapelled-»down the‘ tract by
`a “mass movement", which is similar to ine‘ sgegmenting can-
`tractions seer‘: in the smali intestine, and D('fi3l_.i!'S>Cll"lly several
`times a day. The greatest proizccsriidh of lime in tile (5! .irac‘l is
`spent by the residues of a meal moving through the ccllcm. in
`diarrhoea the rate of rrtcmemenl. through the Colon is fast and
`fluid absorption is incomplete. The ideal delivery syslem to
`the maximal GOIDH should retain the drug within me system
`far approximately 5-8 hours» after administration to the
`paiient. to allow this fair gastric emptying and lransit Waugh’
`the small
`iniesiine and shcuid then disperse and travel
`thmugh the ascending Golan. Oraipreparaiions which are re-
`leased in the salon wcuic!’ has of particular lzalue in {he mean»
`agameni of patients with inflammatory bowel disease-where
`the taping! action of a drug may be cf ‘additional value. Sul-
`pha:-:-alazine isalaxopyfin} is {he mi:st‘effes:t%'ire agent in main-
`tain remission in ulcerative cclitis. its use is limited by adverse»
`reactions including allergy, intolgrence and male. infertility.
`Sillphasalazine ccnsisis oi two compounds, sulphapyridine
`and Syamino salicylic acid (S-ASA) joined by an azca bond
`which is spiitby azo-recluclaéeé: fmrn eolanis baeieria, releas-
`ing the constituents (seé ‘Figure 2).
`
`SAPhan‘nac:euzical’Jcu:nal«~«July 1996
`
`Figure 2: Si‘l.e«’speciflc: drug delivery through Selective pro-
`drug biaactlaxaiion at the target by azaweduclases of anaer-
`obic colonic» baclear-la
`
`Re-‘cent swdies have shown that S—ASA is the active com-
`ponent whiciw both‘ heals and may reduce the number of re-
`iapises in ccxlitis. Sulphapyridine appears to act as the carrier
`rnolecuie far 5-ASA and is iileely in be responsible for most 01‘
`the side effects and allergic reactions-. E3—ASA cannat be sim»
`ply give-nvorally lathe treatment of eoliiis because ii is unsig-
`ble in acid and is also‘; a-bsorbevd by the small intestine and will
`rioi raa ch iis target (the colon)" in eéfective concvemlralien. Oral
`preparations intended to deliver compounds to the human
`colon have been developed as coated capsules corilaining 5-
`ASA and a prodrug form of S‘AS;\ inmiving twis melecules at
`5«ASA linked together with an an band which would be splil
`by bacteria in a similar way lo sulphasala2ine.. A .specific en-
`teric scaled tablet ccmiaining 5—ASA in pellelssmbedded in a
`dis-pelrsible matrix system seems a possihlility for the man-
`agemeril of ulceraiive colitis. Other drugs that are most Elks-ly
`is be presented to lhe calm for tapical release and al:isc:+rp—
`licln are saliaylazobenzciic acid and steroids $1.-sch as premi-
`selone phosphate‘
`
`BiOPHAR !liiA$EUTlCAL iMi3Li{3ATiC}NS EN RELfi['l"lON Y0
`PATHOP1-?¥SK)LGGlCAL CHANGES IN
`
`{EASTR01NTESTINAL DISELAS E
`The pharmaceulicai formulation of the drug substances can
`affect Elie blcsavailabiiiiy oi the drug; We knew how the phar-
`manoidmtic and pharmacadynamic pracassses determine ine
`conceniralions of the drugover a period of time at the active
`site and new pharmacological effectoccurs, New we must an‘:-
`amine how these pmcesses iriieracl with the pmcesses
`underlying the peinfology at
`the disease allowing usaiul
`raiionaiisaiian and interpretation x:sf’dr~ug action».
`Sieatcrrhaea is a izondiimn in w‘hich!l1ere.l3 an increase in
`faecal la! excl-alien as mated in pancreatic dise-ass and occurs
`in gastrintestinai disorders such as caeliac and Crohrfs dis-
`ease, small bowel diverticulosls. vagoiclmy, intestinal reseE~
`lion am} after ingestion of neemycin and choiestyramine.
`‘Subtotal or total villous atrophy may follow chronic‘ treatment
`with p-aminosalicylii: acid, cytotoxic drugs‘, celchiljine, par-
`amomjgcln, mefiormin and siow release putassium chlczfide.
`Villous atrophypccsurs in coeiiac disease and demlaiitis her-
`patifo1'r'mis.Cc:eli:: disease is ihaughl in be caused by sensitiv-
`ity lo cereals and food ccanialning gluten and (alien presents
`as a malabsorption syndre-me. Anaiher fastor influeniiing
`drug absorptlan in coeliac disease might be an increase intha
`pH of thagut lumen or acid miicrociimaté. This mighi 'cor}irib-
`ute to more rapid absorption of basic drugs, such as ;:aropra+
`nelsl. Sn the other hand the abscerptlon of praciz:-ital i3 delayeci
`in caeliac disease. The abscrpiiczn of italic acid is pH de~
`pe;’_a_1de“nl and might, tiierelssieé, be inlfuehced by changes in
`acid .micrsclimaie in patients with coeiiac disease. Ii is poss-
`ible that the permeability of the intestinal mucosa to drugs
`might be situated by disease, but liiiie information is available
`an this point.
`in Crohrré disease there may be -extensive ihi'cl<ening of
`thé gut wall, narréewing of the liimen and saimndaiy changes
`
`26'!
`
`ENDO_OP_1348763
`
`
`
`

`
`
`
`DRUG USE
`
`{A 1&3? Updait:':)
`
`A Guide Far T12:3 Héairhv Praféssiaflszf
`
`This reference work is new availahlla in its St}: §:3;<2itia:>;“1. Easy to use, reiiéhle and prixcéicai if
`sheuéd farm -a part of the‘wf::rence;s'nscd bythe. phanhaifist-6:1 awn-tine daily basis.
`
`Ir'§§:»:'grsggraaba afarxgrr.ns.:;:;& a_z.;.::I'z:2r §ai:_’y'..D?zggg H53, 1.‘; an 22330:}: :.4zss\’:. 2'19:3szpdazslwsg szrae’.-':‘.1's*c:‘:rz-
`Jzkfiza vfzée sozxerasgé :32‘°!1ée-fcarz; iz':z:r ékéswzle fir.-zwz afbrlntkffiéfgprojécfi
`
`Ffzgre .33’ as P£?.'.j5’ rear! saeséféwr gaad rma§;r~rejfere;zce xgmvfér drug zz_mj;;vzr.s1e: daizfa» .:i;:‘E=-sr 5112 ma:*;;vaF'e';_.v
`g;r£J(:F5b£':.2f. pz&:2rmac2'$‘£§* 52329’ :3: cérfizirz z:‘z'ri1%?z};*zs£e;r,«:rce;:s* ezierziiszts" 535:2‘ razzxzffizg peztmzzrrszi 7&7? 161:?‘
`zzé}rz.s*a*i2zre€:z’?2§ sass}: i1a5?£:§aflafxvfiouféezsxirt;9?:rI££$‘§9é’t:V.
`
`1': m»mxg;» ~t¢:3 5:2 :2’ész1~:.=r2’?:a%asS,;>ra*¢r;z?ic;;mer:f“»‘:?i?: g y;::x:z'e;}» UfEf13¥?§e)I§:3'28.§’ w;2’1”:z;».=;:z?’_z!:;-:r::;s'e:'me:s‘-of
`s.Fr§a*'ea.vi¢fv accmsxéfiie §}2f????§a:2‘I£E?f§ s1a:%::%!;':2ira;i*t errzézsrzce rm? »:5c?:3c?j§2:3* sf :!§12r::g,r;y, arm?‘ dérngfifisyiz
`23:5 £1-zc£l2'€:::“6 efriszzg-fikzdgcedaimrzfers.
`./iS3£‘W'f;’ 53,"??.L-‘I HGHA3%’
`BS6-=(g?}za2?ar} Jfffi EA-B
`.356 ('3T2'azz;,*'
`
`5z‘:;ce.=. Ike. {$51 ediszbzz {I985}, mverafnew sinpasriantpismrméxsaiagiarzf‘ azzmrés flaw zzpgiafarea’ an
`2‘??? 5z9‘I¢.z$'§ Afkbéxz fiwfkat. }'?ic?.s’u1?I #311? 4638?? M:'2ic.»r;*é;a?arb*:ék! £11 mgr zigzdirfé; Cfiapézr 3&5" figs been
`e?.r§erm?’-’:.i" fit’ zI=*ze:‘Im$'.«,.* variant tésfifay afcfrug avmpariszanx krgfziafi 1'[E33ma:)1 ére 0fzm?~!0 a'!§£pr::*Sc.r1'-
`:53:/3?&7&‘4§:prfl:7!tI1bH€r.
`Z—”!:::-52 xkzwfizée at £s:).?:3;*&rz3"£>:'1 sftéégragéerrzktv effis .er.‘r".;:;9ca§'&? ar:I!.€‘.<3’e§z72=:?5*-
`.ag§*;-‘:*.m:s; 1;‘/ie::o:&£.«;vz&;é :1'z2?2;;?.:x:2§'éE«.*,£*;r.s?,. z§;‘:'2;2e' ibwernkzg cage»-zerr mm’ §er:zea¥::2ep:@se5* Tée .r.ec=
`1:29»-:1 :.wg.erIk!—!?*fcTd’rwg &3’.§é";*3'efi57 érearz remzskzérz.
`fC?E ?34£§;%»!ZJ£€?
`
`2"u'é'ai}éib3e’from:
`
`33}3}mT3_?)"H0use
`2$3utf= fitreeri,
`Briiaxnfenteinv
`
`_
`‘Ike Beak D::g:&a'rt1:i1eI§¢1
`Thin P‘i1armaceutica.1 fiacéeity efsoutb Africa
`Po Bax 31350
`Tel: (e11T).339-1752
`Braamfcanteir;
`Fax: {G11} ‘4{}3-1399
`2317
`
`
`
`
`
`ENDO_OP_1348764
`
`

`
`CUNTINUING EDLICATIQN
`
`cause» body siores are considerahie, and partly because
`few disoriciers cau$a -Bi; afisarptisn in faii beimsr ihe daiiy
`requiraments. Protein maiabsorptiori may read to hy3;«o~
`pmteinemic oedema, uauaiiy an‘ the icgiwer iimbs. Gaby-
`dration, potassium ioss and muscie weakness can follow
`prefuse diarrhoea; Gaicium deficiency is'ci:2rnmi3n and is
`due pariiy‘ to Vitamin K3 deficiency with impairem a¥:&$Gt;)~
`firm and pariiy :9 caicium binding with unabsomed fatty
`acids-_ This may cause bone pain and faiahy, infantile
`rickets where esieomaiacia may scour in severe aciujt
`coeiiac disease. Thiamine deiisiency {Vitamin 8.1) may
`cause parestheséa and maiabsorptiors of the mainly fat
`soluble. Vitamin Kean head to hypap-rothrnmhinemia with
`bruising and bieedirig tendency (Merck Manna! 1987}.
`Severe rituaflavin {Vitamin B2} deficiency may cause a
`safe tongueand wguiar smmaiitis, bm Viiarrjn A, C3 and
`niacin daiicienciessaidum Cause iziériicai pmbiems.
`
`.3. Man,ifesiaiii5n.s of ma'1a«i:ss.i:-rption due to an underi;-r’ing
`disease: same diseases that cause maiabsarpiicrz. have
`ciistinisiiy ciifferentnlinicai preseni:aIion._ eg, ihejagzinciice
`cf biliary cirrhasis and pancreaaia carcinoma, the abdo-
`minai angina oi mesenieric ischaemia, the baring centre!
`ahdc;-minai pain ci C5’!i‘{}.E‘:i'G pancreaiitis. and the severe,
`persistent‘ uicar dyspegsia -of the .Z<;'}iinger«Ei_iis»3n syn-
`drome (syndrcrme caused by.a_.gastrin«s‘ecre€ing;
`tumour
`of me pancreas. ;:.mdu::;i:3g a high concentration at hy-
`drochioric acid in the stomach-: ulcers are farmed in the
`oesephagus-andupperiniesiinaiiraci).
`
`:1.
`
`Sympwms associated wizh the ageing processfieideriy}:
`Stmctu-ra-i and iunct-ianai changes in aha gastrcziniestinai
`iraci _have garficuiar significance: on ihe éifiectixzaeness sf
`r:-rally administered medicines. Gastric ‘acid output and
`peristaiiic activity decrease with age. The resuii: is a reta-
`Iixrerg high iriaidenrze of anaemia .ris<:essita2ing supple-
`mentary iricrganic ircn therapy, which can form newsh-
`sorhabie iron c<:«rr}plexes’w~'ith tetracycimes and sgrntixertic
`peniciiiins ii‘ admin-isiereci conuurrentiy. Siowed gs-.”sir§<":
`muscular aciiviiy, decreased emptying time ‘and the
`rising (ii the pH oigasiric juices may irr¢r'easa'tir:e,irritat~
`Eng effiétt sf somedrmgssuch as aspirin or phenyiain, be»-
`‘cause cii th’eii'e’:(irended .tirne~in the stomach.
`
`
`
`Tabie 5: Maiabssarpticsn fine in disease states resu hing {mm
`impaired digestion
`
`‘ I
`
`mpaired digestioh
`resuiting mam
`
`Conditions
`
`inadéquate mixing
`
`Gasiroerzierostomy
`Biifrmh .iE.i;asiro~eciomy
`Gastrrzcolic fistula
`
`insufficient digestive
`agents
`
`improper miiieu
`
`Chronic pancreat-iiis
`»Gystic fibrasis
`Chranic éiver iaiiure
`Biliary absiruciiim
`Riaciasia
`Sucrasisdsoniaitase deficiency
`
`Zoliiinger-Eiiiisonsyn{§rcm1e.ii0w
`ducderzaii pi-i}
`Bacteria? evergrowth-biind maps
`iderzonhlgaiion sf biie salisj
`Diverticu Ia
`
`'
`
`-263’
`
`ENDO_OP_1348765
`
`in matiiiiy. The effects on cirug absorption are variabie and
`unexjaiained. The abficrption at rifampicin is unaltered, that of
`ciindamyciri and suiimamethoxaznie is apparentiy increased,
`while the absorpfion oferythrornysin-staarateis reduced.
`in smaié bowei iiiverticuiesis, which is we at the most im-
`panant pat-iwphysioingiizzai candiiions in which there is a shiii
`in ‘gm iiciza in Va preriominamiy anaerabic popuiaiiiran which
`may be respesibie fer sieaiarrhoea arifi maiaizaorptien, Ai-
`though in such circumstances increased meiabviism cf drugs
`by intestinal bacteria might be expected, absorption does not
`seem to be decreased.
`A
`Exampies of ciinicaiiy importani changes in drug 3bS{:ar;3-
`{ion in paiiafits with gasiroiniesrinai disease are as ioilowsz
`deiayed gastric empryinghas baen shown ta be responsible
`for merapautic faiiure cf ievodopa in patients with Parkinsorfs
`disease. Achierhyflria {absence of hydroehimia. acid) czccurs
`in pemiciaus anaemia and is;c:am2wr.'in in the eideriy. The re—
`suiting changes in pH wiii infiuence cimg ciissoiution and
`pisssiiziiy gastric emptying rates and so after the absorption of
`many drugs. Variable affects cf 3.-ug absorpiian have been
`repcrteci after gastric surgery, Hgpoihyreidism faiiing is re~
`srsand to arai "t§"iyrCsXi.r‘t9 0'r’ir§iGd0’£h3rmnine is ariimportant but
`rare compiication of caoeiiac .di1aeas»a. The ri5i<: of cznkimcnaiezv
`zoia induces? apiastir; anaemia is g—reatiy increased in ifiatienis
`with coaiiacdisease and foiaie riiepietiari and cst_e;omaiaci_a,is
`an imporzant risk with prolonged anzi—c::m‘ruisant theramr in
`ccietiac: disease. The deiayed .absorption of many drugs in this
`conditinn is uniikeiy to be oi.therapeuiic significance.
`Eiiarrheea, with accelerated remark intesiiriai transit may
`have important effects can drug absorprirun, pariicuiariy with
`the siowiy iii-ssciiving or stew reiease _pr9;;3araii,onsi
`iruzieed,
`diarrhoea has been >hi8ԤCi reszicniaiizie for failure of orai contra-
`cepiittzn.
`
`MA%.AE5G'RP'T!QN DUE TO STRWCTU HAL AND
`FUNCWGNAL C-I-{Afr-1G ES
`
`Many difisrant iciiseasas or their consequences Cat‘: cause
`maiabsorpiitan eiiher by means oi impaired ziigestiarr {Tahie
`5}, nrimpaired absibrpfion, {Tabie.,6}.,
`
`Signs and symptams associated with malabsarption
`
`>1. Manifestations directly attributabie to maiabsarptien:
`weight loss, gicssitis, aazpopadai, spasm, absent iendcin
`reflexes, wt-aneous bruising, abziaminai distensirjn, fiat»
`uienca, gbdominai bieaiing and disscimiort due to in-
`creased buik cf intesiinai »c<miems and gas productirsn.
`flermatiiis herpaiiforrais isciien associated with a miio
`degree of z:eeiiac—iii<e enieropaihy. Diarrheea is not ai—
`ways present; Sometimes siieatorrhoea accurs —— pate,
`sfflfi, buikgi, maiodcifaus .Sto0‘is,Miriai siicicrio the side of ihe
`ioiiai how}, er float and are tfiffirsuii 1:3 iitish away. This
`kind sf 3190!‘ is most iiiazeiy to occur in coeiiac disease or
`trosicai sprue. The stools in chronic pancreatic disease
`may appear grezasy with frag ilcatirag gicibuies of fundi-
`gested dietary fat ifrigiycerides} because of pancreatic
`lipase deficiency (Merck Manual 198?}, Steaierrhoea
`can be '§)}TESEi"£f wizhsut fisrici abnormalities at this stz:-oi.
`Expiosive diarmaea with .abdominai biciating arid gas af-
`ter miii: ingestion paints in iactasa i:Iei_ic;ienoy (aiactasia).
`These effects are seen more in the eideriy and [marma-
`€§§5i’i‘!1¢Iit1i€0!‘ii“i}§
`csi‘ drug "therapy can piayan important roie
`in opfimising drug use inihe eéderiy.
`
`2.
`
`liiiartifesiazicins céueto deficiencies secendary to maiab-
`sormion: the range and severity cf nuiritianai deficiency
`resales to the s'e‘sréri%~yr of “the ‘primary diseasa and me
`eras of the GI tract vinvoiveci. Many patients with maEab—
`sorgation are anaemic, usuaiiy due to deficiencies of iron
`(mérsrocyiic anaemia) and ioiicacici fimegaiobiasiic ahea-
`mia}. Vitamin B12 ‘deficiency’ is‘ unsomman, partly be-
`
`SA Pharmaceutical Journai -- Jmy 3 990
`
`
`
`

`
`CQ§}:l§}§NGiEfi1l(ZiATIQN‘
`
`solves so rapidly that most is in snlulion before mucli has "en-
`tered. the .irlte$iine,__geelric emptying Iclearly influences the
`raise all drug absarpiian. Hasiening gasirlc empmng, for'e>z—
`ample, qulckefis émg ab3i3i'l‘.Di‘i‘0rl from eeluzltm: some drugs
`do not disslxzlilse in the stomach, whereas‘. inme iniesline both
`rapidly clissnive and pass across the §i5ileslina-l- wall. C-‘:'a~3ll'li':
`empiying; iben tlréimatlcailgs alfestlzi {fie lime and gaerhaps the
`rale of clrug iabsorptien. An‘ enieric mated pmclucl is an" ex-
`treme example of this situaiien. On‘ the eihe‘r hand, same
`drugs such‘ as grlseoi-ulvln, lhai is sparingly’ soluble in bolh
`gastric and ln?es*il;é‘a.l fluids, these may already be lnSUfii{:ie‘nl
`lime fer d%ssalui§en and absohpllan when this drug is-aclmlnlésw»
`iered as a _scd:'d. with a fixed Sl"l£':l:‘l'tii‘n«'e within me email inies~
`tine. the _aili>‘w release of iauch adriug {mm ‘the stomach in.-
`creases ihe total time if is in the intestine and decreases the
`ccncentratim at any one site. Eésili conditions femur in;
`creamed beioavailability. As mentioned, feed,_ la: in parficular;
`delays gastric enipiying, anal ililsijelay may be one 35% the ex»
`planallons" for the’obse'n/em‘ increase in me "blo3vallabilE13; 0%
`gfiseefubiirl when ‘taken with _a
`laity’ meal.
`it appevars that
`'pl1§,rsic»lt:g’ical éllscriminatiiéri 1'cvl‘m'ea’l solids and liquids takes
`place in the stomach rather ihan the email bcxwei. Small ln'tes=
`line transit lime ‘zstremarkainly c0nslaI%t.irrespacllxre ei size or
`the dosa§e‘fo?m,- densiiyor presence cal iced, Single unit do-
`sage terms‘ may be held for lC}Tl13.. periods a! the ilaocaecral
`vaiye bemre entering the salon. Trar_1s.it time of dosage l‘_c;;-ms
`is shorter when fibre-centaining food is cansumed, as dietary
`fibres affect the digesiion process. Subsequently as the in»
`tesilnal fluid .and contenls move late tllelarge .lnl§2sii'ne and
`water is reabseit-edl the resulting. compaiziinn :21 the solid
`conienls may severely limit funliar zfisscziution and hence atw
`30 rptlan tn’ idreg.
`Chemical factors afieetlng drug abSUf;iflDE_<3G 5:3 by lumi-
`enclng the slate €)l":lie»: drug in the §f'l‘i9:5°£'lll'E. Thus tetracycline
`antibiotics lslnfcil sirangly tevcalcium inn and .cel»:;iun:: rich food,
`fiespfldfsiailgg niilk) prexréfits their abs:-rpticnv. Sémllariy. the use
`ml’ liquid palafiln as a iaxatlsse will retard the abS<24€'pfi£3fi oi lipe-‘
`.p%lillc.eubst-ances. suxsh as Viiamirl‘ K.
`
`Greg‘ abscirpiion in paiierile will’: gasiminiesiinal cfiseese is
`‘variable and unpradicialjlxe. This varlailen is uftezfi pearly cm-
`relaied with the site and severity" of diseasaxchemiizal strun-
`ture» al-"id-C}'lQ_miC8l pmpenies of :3he"d'mg_ s’:udiecl. Overall. the
`clinical si_gm'ficansa at abnnrmal drug ebscrpiion is unknown.
`hutlhere l_1eve»i3een oc§¢aelaénal.lreports el iherapeuiia failure
`attributed to ihis‘ca’l.:4se {Table 71.
`
`Table 7: changes in blood le#e.ls of some drugs attributed to
`Gaelic; or Groizn s Disease.
`
`Disease V nrugs siieiixihg‘
`cmiditian incfeasers
`-bicodlevels
`
` V
`
`Drugs skewing
`dadreasea
`bluodwltels.
`
`Cuelie
`disease
`
`Aspirin
`‘C_e‘;rhalexin,
`E_r§£tfir0lTIyCifi’Sleafal_e'
`Fusidiclacld
`Pmpranelel
`Suliameilioxazule
`
`Anelaminophen
`Dlg::>xin-
`Pi*~zam:J.lc‘illifl
`Praclolclll
`
`Crohifs
`disease
`
`Ciimrlamycirl
`Sediumfvsidaze
`Suifatnelhaxazole.
`
`Aceiaminaplien
`Cegihalekin‘
`vfiiryihmmylcin stearate
`_l.inton‘ly't2in
`Trimethrsprim
`
`Sfl:Tydskr§f.vi:ApteeKwese~Julie 1.998
`
`ENDO_OP_1348766
`
`Table 8‘: Maleb$0r;§iién asseciateij with lmgtxalred pl’!ySl0l(}gi~
`cal cenditions
`
`' E
`
`condiiiet-ls
`mpaiiedahsorbtlorl
`resulting from
`
`Acute abnermal
`egilheliurh
`
`Cl‘l:‘rc~nic‘ abnormal
`epithieliu'm
`
`Short bowel
`
`Acute inieslinal infecticné
`Neemycln
`Aicolwel
`
`Coeliaceisease
`Tropical sprue
`Wiilppleét disease
`Amylcéd
`lsthaernia
`Crohn’s disease
`
`lrfiestlhai resectlcln lor“{3rohn’s
`disease
`*v’:3lvulu‘s
`IniU3SUSi§8Dil{>l"l
`lnfarclinnv
`
`lmpalrecl iranspori
`
`Blocked leafs-als— lymphoma.
`Lymphangiec-tasia
`Addlsorrs disease N? iranspori
`enzyme
`? Abeiallpapmleihemia
`
`
`Modified from The Merck fielaeual 15;? ea’ {$987)
`
`Changes in me-lesion during ageing cause cnnsllpaiizzon,
`one in‘
`lime more lrcrublesome funcslonal pmblerns cf the
`elderly. The result may be overuse all iaxaalivee, which can
`lead in dehyizlratlcrz, hypekalaemla and reduced absorptlen of
`fafisoluble vitamins. Qohsllpeting drugs, such as certain arr
`taclds, antlhakpartansives; anlidlielineraglce, aratideplfessanls
`and ‘me phenothiezinesi must, therefore, be used wié-h care in
`the elderly.
`it aepeare that drugs which are ainsarbed’ by
`in general.
`specific transperi pmceseas are l’l'1<’.‘xl"é
`lil-iely to be affeefed
`than those iha1"are'abscrbed by passive difiuslan. The ab-
`sorption by active transport of galactose, calcium, thiamine
`am: iman la reduced in the’ elderly, winesteae studies of ease:
`rzetamol,
`~as;:niriri, phenylbutazenje and sulphainethizole
`demonstrated normal absergoiicrn oi‘ these passively absorbed
`drugs in the elderly,
`CONCLUSION
`
`with wider appieclaficn of pharmacnklnetlc and -pliarmacady
`riamic; principles and ma intieszlucrtien of therapeutic drug
`monitoring. a variety? i>E'c'ontro‘llenl release’ ma: dasage forms
`has been introduced over the last decade. Coniretled cm»
`slant drug input mlghi prmxide greater‘ seleefivlty of drug ac:«
`‘lien and reduced toxicity by avoiding» ihe successien of peaks
`.and troughs of drug concentration associated with con-
`lxemienal therapy. Drug absorplien from many of these do»
`sage forrns depends er’/{he location elihe delivery system in
`the gaslrairlleslinal tract. }ndividl1al’difierence.s in the exterit
`eel awbsorpiiori have pharmacoklnelld’ ctiizsequences,--similar to
`lhose arisliig from -changes in
`form iorrnuiafiong
`Asihe meuih ta anus transii time is typically 1 ti.) 2‘ days,
`ihese data an gastric and small intestinal transit" ‘limes indi‘-
`cale that, for the m.aloriity elihls time, lngeslecl sczlids age in
`eiiiier the large bowel or the rectum. Wilh ihe ;:rh3ssie¥'ogi:
`iniermaiion given. the poe‘s‘il:éte rale arf gastric emptying and
`intestinal transit in the absorption‘ of drugs glven in ‘mild
`dosage" farms ce_.n~ be understand. C-ansidezingi tlial malny
`corwenticnal tablets and capsules, in which the drug »:lis—
`
`‘
`
`284
`
`
`
`

`
`C(§NTINUINGbEDUCAYiGN
`
`To summarise, aviarge number of faciizsrs can -influence
`
`systems. drug form. excipients, cirug amount, administrafian
`scheduie, route of administration. physiological factors, such
`as age. sex, body weight. ganatic, nutritional state, disease,
`pregnancy, gut flora, gasiroiniesvtinai ma-iiiity, renaifunetisn.
`physicai aciivitg: and dieiary facmrs are also important and
`they may Inqreasediug ..E.bSOFpi!O_hQt:33"feC1£?fug metabolism.
`drug excretion. drug receptor; site znteractsans and finafly,
`marmaccaiogica! factors can affecfdrug absorption. Effect of
`::f::; :21:
`iary flow, local brood flow. urinary pH. tdierance and envirorv
`memal
`factars. are an 'im;:or2am determinants of drug
`aijggrpfign and response,
`
`REFERENCES
`1. Davis 83, Hardy JG and Fara JW (198%): Trarjsit of
`plharrnaczeuticaifldasage farms through the smafi m*tes-
`me’~GUt' 27:‘38‘°‘8g2

`2. Hartiaia K (‘i§i?3): Metaboiisrn of. hormones. drugs and
`ether‘ subs

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket